EUVIMEDObjevte EUVIMED
Crossref

Circ_0044362 Facilitates the Progression of Epithelial Ovarian Cancer via Enhancing HOXB4 Transcription to Activate the RUNX1/IGFBP3 Axis

Shengtou Ye, Han Wu, Junjiang Liu, Jianguo Zhou, Sisi He, Na Li iD

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23905 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Shengtou Ye and 5 co-authors. Institution: Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China. Major MEDLINE topics: Homeodomain Proteins, RNA, Circular, Core Binding Factor Alpha 2 Subunit, Ovarian Neoplasms. 40 references. Funded by: This study was supported by National Natural Science Foundation of China (Grant 82160538)., National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Increasing numbers of studies have elucidated the emerging roles of circular RNA (circRNA) in cancer progression. However, the function of circRNAs in modulating their parental genes in ovarian cancer remains poorly understood. In this study, we identified that circ_0044362, a circRNA derived from homeobox B4 (HOXB4), significantly promotes the expression of its parental gene HOXB4 in ovarian cancer. Functionally, circ_0044362 promotes the malignant phenotypes of ovarian cancer cells. Further analysis revealed that circ_0044362 facilitates the transcriptional activation of its parental gene HOXB4 by directly guiding U1 small nuclear ribonucleoprotein (snRNP) to its promoter region, thereby enhancing the oncogenic behaviors of ovarian cancer cells. Furthermore, HOXB4 positively regulates runt‐related transcription factor 1 (RUNX1) expression, with RUNX1 serving as a transcription factor to promote the transcription of insulin‐like growth factor binding protein‐3 (IGFBP3). Notably, inhibitors of either HOXB4, RUNX1, or IGFBP3 could reverse the oncogenic activity mediated by circ_0044362. Collectively, our findings reveal the involvement of the circ_0044362/HOXB4 pathway in ovarian cancer progression and provide potential therapeutic strategies for ovarian cancer treatment.

Subjects

MeSH terms (MEDLINE)

Homeodomain ProteinsRNA, CircularCore Binding Factor Alpha 2 SubunitOvarian NeoplasmsTranscription FactorsCarcinoma, Ovarian EpithelialInsulin-Like Growth Factor Binding Protein 3HumansFemaleGene Expression Regulation, NeoplasticDisease ProgressionCell Line, TumorCell ProliferationAnimalsMice

Author keywords

circular RNA (circRNA)homeobox B4malignant progressionovarian cancertranscriptional regulation

Substances

Homeodomain ProteinsRNA, CircularCore Binding Factor Alpha 2 SubunitRUNX1 protein, humanTranscription FactorsHOXB4 protein, humanInsulin-Like Growth Factor Binding Protein 3

Authors and institutions

  • Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi, China.

ORCID profiles: Na Li

Funding

  • This study was supported by National Natural Science Foundation of China (Grant 82160538).
  • National Natural Science Foundation of China

Cite

APA

Ye, S., Wu, H., Liu, J., Zhou, J., He, S., & Li, N. (2025). Circ_0044362 Facilitates the Progression of Epithelial Ovarian Cancer via Enhancing HOXB4 Transcription to Activate the RUNX1/IGFBP3 Axis. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23905

Vancouver

Ye S, Wu H, Liu J, Zhou J, He S, Li N. Circ_0044362 Facilitates the Progression of Epithelial Ovarian Cancer via Enhancing HOXB4 Transcription to Activate the RUNX1/IGFBP3 Axis. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23905

BibTeX
@article{Ye2025,
  author = {Ye, Shengtou and Wu, Han and Liu, Junjiang and Zhou, Jianguo and He, Sisi and Li, Na},
  title = {Circ_0044362 Facilitates the Progression of Epithelial Ovarian Cancer via Enhancing HOXB4 Transcription to Activate the RUNX1/IGFBP3 Axis},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23905}
}
Start for free →